United States· US:85816-6034_53232825-2634-d0b4-e063-6394a90a14f9
BM KALI PHOS POTENCY
A medicinal product containing dibasic potassium phosphate, registered in United States by BM Private Limited.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DIBASIC POTASSIUM PHOSPHATE
- Manufacturer
- BM Private Limited
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc118581660341500 mL in 1 JAR (85816-6034-1)
- ndc1185816-6034-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dibasic potassium phosphate in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandK-FosfosterilOrion Corporation Orion Pharma
- FrancePHOSPHATE DIPOTASSIQUE RENAUDIN 174,20 mg/ml, solution pour perfusionLABORATOIRE RENAUDIN
- Japanリン酸二カリウムテルモ
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Spain · Fosfato Dipotasico 1m Fresenius Kabi
- France · Phosphate Dipotassique Renaudin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7f9b44b6-474b-4234-b4bf-bd1254844fc6 GET /v1/drugs/7f9b44b6-474b-4234-b4bf-bd1254844fc6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "6",
"substance": "DIBASIC POTASSIUM PHOSPHATE",
"productndc": "85816-6034",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "[hp_X]/mL",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about dibasic potassium phosphate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.